REVANCE THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Revance Therapeutics, Inc.

NEW ORLEANS, Dec 11, 2021 / PRNewswire / – Kahn Swick & Foti, LLC (“KSF”) and KSF Affiliate, former Attorney General of Louisiana, Charles C. Foti Jr., Remind investors that they are up February 8, 2022 Lead plaintiffs in a securities class action lawsuit against Revance Therapeutics, Inc. (NasdaqGM: RVNC) if they have the company’s shares between November 25, 2019 and October 11, 2021, including (the “Class Period”). This action is pending in The United States District Court for the Northern District of California.

(PRNewsfoto / Kahn Swick & Foti, LLC)

What you can do

If you have bought Revance shares and would like to discuss your legal rights and how this case could affect you and your right to reimbursement of your economic loss, you can contact Lewis Kahn, Managing Partner of KSF, free of charge and without obligation under 1 -877-515-1850 or email ([email protected]) or visit https://www.ksfcounsel.com/cases/nasdaqgm-rvnc/ to learn more. If you want to be the lead plaintiff in this class action lawsuit, you must file a motion with the court February 8, 2022.

About the lawsuit

Revance and some of its executives are charged with failing to disclose material information during the class action period in violation of federal securities laws.

on October 12, 2021, the company announced that on July 2, 2021, the FDA reported issues identified during the inspection of the company’s DAXI manufacturing facility in Northern California, including:[t]The current manufacturing process is not the process proposed for approval ”and that“ the quality unit lacks the responsibility and authority to control, review and approve outsourced activities ”.[.]”

On the news, Revance’s shares fell $ 6.85 per share, or 25% to close on $ 20.45 per share October 12, 2021.

The case is Aramic LLC v Revance Therapeutics, Inc., No. 21-cv-09585.

About Kahn Swick & Foti, LLC

KSF, to whose partners former Louisiana Attorney General Charles C. Foti Jr., is one of the leading boutique securities litigation law firms in the country. KSF assists a wide range of clients – including public institutional investors, hedge funds, asset managers and private investors – in finding reclaims for investment losses resulting from corporate fraud or misconduct by listed companies. KSF has branches in new York, California, Louisiana and New Jersey.

The story goes on

To learn more about KSF, visit www.ksfcounsel.com.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Executive Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

Cision

Cision

View original content to download multimedia: https://www.prnewswire.com/news-releases/revance-therapeutics-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick–foti-llc-reminds- Investors-with-losses-in-a-surplus-of-100-000-the-lead-plaintiffs-deadline-in-class-action-lawsuit-against-revance-therapeutic-301442664.html

SOURCE Kahn Swick & Foti, LLC

Comments are closed.